BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30058241)

  • 1. Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.
    Karampetsou MP; Comte D; Suárez-Fueyo A; Katsuyama E; Yoshida N; Kono M; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2019 Jan; 71(1):99-108. PubMed ID: 30058241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of expression and function of the co-stimulatory receptor SLAMF1 in immune cells from patients with systemic lupus erythematosus (SLE).
    Liñán-Rico L; Hernández-Castro B; Doniz-Padilla L; Portillo-Salazar H; Baranda L; Cruz-Muñoz ME; González-Amaro R
    Lupus; 2015 Oct; 24(11):1184-90. PubMed ID: 25920347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
    Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
    Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
    Marken J; Muralidharan S; Giltiay NV
    Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation.
    Chatterjee M; Rauen T; Kis-Toth K; Kyttaris VC; Hedrich CM; Terhorst C; Tsokos GC
    J Immunol; 2012 Feb; 188(3):1206-12. PubMed ID: 22184727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen up-regulates interleukin-21 production by CD4(+) T lymphocytes in patients with systemic lupus erythematosus.
    Lee J; Shin EK; Lee SY; Her YM; Park MK; Kwok SK; Ju JH; Park KS; Kim HY; Cho ML; Park SH
    Immunology; 2014 Aug; 142(4):573-80. PubMed ID: 24495300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
    Comte D; Karampetsou MP; Yoshida N; Kis-Toth K; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2017 May; 69(5):1035-1044. PubMed ID: 28076903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production.
    Liu Z; Liu S; Zhang Y; Zeng W; Wang S; Ji P; Pan M; Zhu C; Wang Y
    Cell Immunol; 2021 Oct; 368():104420. PubMed ID: 34418679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Di-(2-ethylhexyl)-phthalate interferes with T-follicular helper cell differentiation and cytokine secretion through signaling lymphocytic activation molecule family member-1.
    Han Y; Wang X; Pang X; Hu M; Lu Y; Qu J; Chen G
    J Immunotoxicol; 2019 Dec; 16(1):155-163. PubMed ID: 31403359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
    Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
    Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6
    Facciotti F; Larghi P; Bosotti R; Vasco C; Gagliani N; Cordiglieri C; Mazzara S; Ranzani V; Rottoli E; Curti S; Penatti A; Karnani B; Kobayashi Y; Crosti M; Bombaci M; van Hamburg JP; Rossetti G; Gualtierotti R; Gerosa M; Gatti S; Torretta S; Pignataro L; Tas SW; Abrignani S; Pagani M; Grassi F; Meroni PL; Flavell RA; Geginat J
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7305-7316. PubMed ID: 32184325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.